Catapres-TTS (Clonidine Hydrochloride Transdermal) - Summary

CATAPRES-TTS SUMMARY

CATAPRES-TTS^® (clonidine) is a transdermal system providing continuous systemic delivery of clonidine for 7 days at an approximately constant rate. Clonidine is a centrally acting alpha-agonist hypotensive agent.

CATAPRES-TTS (clonidine) is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other antihypertensive agents.

CATAPRES-TTS NEWS HIGHLIGHTS

Published Studies Related to Catapres-TTS (Clonidine Transdermal)

Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. [2006.03]

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. [2003.04.01]

Transdermal clonidine: does it affect pain after abdominal hysterectomy? [2003]

Effects of chronic clonidine administration on sympathetic nerve traffic and baroreflex function in heart failure. [2001.08]

Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure. [1998.08]

more>>

Clinical Trials Related to Catapres-TTS (Clonidine Transdermal)

Clonidine Versus Midazolam for Premedication [Completed]

Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome [Completed]

Epidural Fentanyl-Bupivacaine Versus Clonidine-Bupivacaine for Breakthrough Pain in Advanced Labor [Not yet recruiting]

Clonidine Versus Adenosine to Treat Neuropathic Pain [Active, not recruiting]

Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children [Completed]

more>>